Skip to main content

Table 4 Clinical characteristics of children and adolescents with T1DM in Jugol General Hospital and Hiwot Fana Compressive Specialized University Hospital, Harar, Eastern Ethiopia, November 15, 2022 to January 15, 2023. (n = 231)

From: Poor glycemic control and its associated factors among children with type 1 diabetes mellitus in Harar, eastern Ethiopia: A cross-sectional study

Variables

Category

Frequency

Percent

Age at Diagnosis (years)

1- 3

18

7.8

4- 6

35

15.2

7- 12

135

58.4

13- 18

43

18.6

Duration of DM(years)

 < 1

55

23.8

1- 5

119

51.5

 > 5

57

24.7

Duration of medications(years)

 < 1

56

24.2

1- 5

117

50.6

 > 5

58

25.1

Insulin regimen

Premixed NPH/RI

6

2.6

Nonpremixed NPH/RI

213

92.2

NPH alone

12

5.2

Insulin dosage

 < 0.8 IU/Kg

84

36.4

0.8–1.2 IU/Kg

119

51.5

 > 1.2 IU/Kg

28

12.1

Storage

Refrigerator

109

47.2

Pot

50

21.6

other

72

31.2

Who administers

Child himself

174

75.3

Caregivers

54

23.4

A child with the support of a caregiver

3

1.3

Missed dose

No missed dose

210

90.9

1 missed dose

21

9.1

Glucometer

yes

174

75.3

No

57

24.7

Frequency of BGM

 ≥ 3 × weekly

156

67.5

1–2 × weekly

18

7.8

Non-per week

17

24.7

Co-morbidities

Yes

13

5.6

No

218

94.4

Type of co-morbidity

Epilepsy

6

2.6

Cardiac diseases

1

4

HIV/RVI

2

0.9

Others

4

1.7

None

218

94.4

Dose injected by a caregiver

None

111

62.7

1 injection

5

2.8

All injections

61

34.5

Dose supervised by a caregiver

None

104

58.8

1 injection

2

1.1

All injections

71

40.1

Participation of caregivers

No participation

70

39.5

Reminds the child

32

18.1

Sets up the meter

75

42.4

Medications that increase blood glucose

Yes

8

3.5

No

223

96.5

  1. DM diabetes Mellitus, BGM blood glucose measurement, NPH/RI neutral protamine Hagedorn/regular insulin, IU/kg international unit per kilogram, HIV/RVI human immune deficiency virus/retroviral infection